Celldex Therapeutics (CLDX) EBITDA Margin Growth (5y) (2015 - 2026)
Celldex Therapeutics (CLDX) EBITDA Margin Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Celldex Therapeutics | 1.72 Mn | 1.72 Mn | -1.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -56.05 Mn |
| Dec 31, 2025 | -7.14 Mn |
| Jun 30, 2025 | -393,186.00 |
| Mar 31, 2025 | -831,236.00 |
| Dec 31, 2024 | -330,388.00 |
| Sep 30, 2024 | 53,570.00 |
| Jun 30, 2024 | -13,990.00 |
| Mar 31, 2024 | -2.48 Mn |
| Dec 31, 2023 | -46,567.00 |
| Sep 30, 2023 | -189,338.00 |
| Jun 30, 2023 | -1.18 Mn |
| Mar 31, 2023 | -41,600.00 |
| Dec 31, 2022 | -99,017.00 |
| Sep 30, 2022 | -599,041.00 |
| Jun 30, 2022 | -2.16 Mn |
| Mar 31, 2022 | -1.11 Mn |
| Dec 31, 2021 | -423,006.00 |
| Sep 30, 2021 | -1.23 Mn |
| Jun 30, 2021 | 194,396.00 |
| Mar 31, 2021 | 31,109.00 |